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Abstract
Background—The combination of highly caffeinated ‘energy drinks’ with alcohol (ethanol) has
become popular among young adults and intoxication via such beverages has been associated with
an elevated risk for harmful behaviors. However, there are discrepancies in the human literature
regarding the effect of caffeine on alcohol intoxication, perhaps due to confounding factors such
as personality type, expectancy, and history of exposure. Animal models of co-exposure are
resistant to such issues, however, the consequences of voluntary co-consumption have been
largely ignored in the animal literature. The primary goal of this work was to characterize a mouse
model of binge caffeine and ethanol co-consumption employing the limited-access ‘Drinking-in-
the-Dark’ paradigm (DID).
Methods—Caffeine was added to a 20% alcohol solution via DID. Alcohol/caffeine intake,
locomotor behavior, ataxia, anxiety-like behavior, and cognitive function were evaluated as a
consequence of co-consumption in adult male C57BL/6J mice.
Results—Caffeine did not substantially alter binge alcohol intake or resultant BECs, nor did it
alter alcohol’s anxiolytic effects on the elevated plus maze or cognitive interfering effects in a
novel object recognition task. However, no evidence of alcohol-induced sedation was observed in
co-consumption groups that instead demonstrated a highly stimulated state similar to that of
caffeine alone. The addition of caffeine was also found to mitigate alcohol-induced ataxia.
Conclusions—Taken together, our mouse model indicates that binge co-consumption of
caffeine and alcohol produces a stimulated, less ataxic and anxious, as well as cognitively altered
state; a state that could be of great public health concern. These results appear to resemble the
colloquially-identified ‘wide awake drunk’ state that individuals seek via consumption of such
beverages. This self-administration model therefore offers the capacity for translationally-valid
explorations of the neurobiological consequences of binge co-consumption in order to assess the
public health risk of this drug combination.
Introduction
Mixing alcohol (ethanol) with caffeinated beverages has long been a common practice (e.g.
rum and cola). The rise of ‘energy drinks’ (containing large quantities of caffeine; ~80–300
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mg/container), however, has changed how people consume caffeine and alcohol
combinations. These beverages are characterized by a blend of naturally-occurring
stimulants (e.g. caffeine), sugars (e.g. glucose), and amino acids (e.g. taurine) (Marczinski et
al., 2012). Although there are many purportedly ‘performance-enhancing’ ingredients in
these beverages, caffeine is largely considered to be the primary psychoactive ingredient
(Giles et al., 2012, Peacock et al., 2013b). As energy drinks contain more caffeine than
standard cola (~30–50 mg) and alcohol mixers are often consumed in a binge fashion (e.g.
‘Jagerbomb’ shots), a larger quantity of caffeine is allowed to accumulate, enhancing its
potential to alter alcohol intoxication. This may explain, in part, demonstrated associations
between co-consumption and a more hazardous intoxicated state than alcohol intoxication
alone.
There is some evidence that energy drink co-consumption is associated increased alcohol
intake (O’Brien et al., 2008, O’Brien et al., 2013, Thombs et al., 2010), although this has not
been consistently demonstrated (Verster et al., 2012, de Haan et al., 2012). An additional
concern is that co-consumption has been associated with an increased risk for dangerous
behavior such as driving under the influence (Thombs et al., 2010), unwanted sexual
encounters (O’Brien et al., 2013) and aggression (Jones et al., 2012). The notion that
caffeinated alcohol consumption is more hazardous has been contested, however, arguing
that the likely higher incidence of co-consumption among sensation-seeking persons
muddies the relationship (de Haan et al., 2012). Contradictory evidence recently showed,
however, that co-consumption was associated with higher odds of hazardous behavior; even
after controlling for sensation seeking tendency and the amount of alcohol consumed
(O’Brien et al., 2013). It therefore appears that the consequences of co-consumption, indeed,
warrant public health concern and further study.
Some human studies have found the addition of an energy drink or caffeine to alcohol to
attenuate alcohol-induced decrements in reaction time (Heinz et al., 2013) and short-term
memory (Drake et al., 2003), as well as increase subjective stimulation (Peacock et al.,
2013a). However, others have found no such effects on certain measures of cognitive/
psychomotor performance (Marczinski and Fillmore, 2006, Verster et al., 2012, Peacock et
al., 2013a) or subjective intoxication (Alford et al., 2012). Such discordance is not surprising
given differences in when the testing interval occurred following consumption and the wide
range of caffeine and alcohol doses employed in these studies.
Animal models can mitigate the influence of potential confounds in human studies such as
expectancy, personality, and degree of prior alcohol and/or caffeine experience. However,
little work has been published in this regard (for review, see Lopez-Cruz et al., in press).
The available literature suggests that caffeine administration may both increase (Kunin et
al., 2000) and decrease (Rezvani et al., 2013) ethanol intake, as well as reduce various
aspects of ethanol-induced motor (Dar, 1988, Yacoubi et al., 2000) and cognitive
impairment (Spinetta et al., 2008). Caffeine has also been demonstrated to enhance the
locomotor stimulant properties of ethanol in mice (Hilbert et al., 2013). One interpretational
issue with the existing studies, however, is that such consequences following voluntary co-
consumption have yet to be explored, hindering the translational validity of their findings.
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In the current study, caffeine was added to the 20% alcohol solution used in a mouse model
of binge-like alcohol consumption, Drinking-in-the-Dark (DID). As caffeine is largely
considered to be the primary psychoactive ingredient in ‘energy drinks’, we chose to focus
on this compound. An altered intoxication state, appearing to mirror findings from human
studies, was observed; thereby bolstering enthusiasm for a translationally valid animal
model with which the neurobehavioral consequences of this drug combination can be
explored.
Methods
Animals
Adult male (PND 56 ± 3) C57BL/6J mice were purchased from the Jackson Laboratory (Bar
Harbor, ME) and allowed 10–14 days to acclimate before experimentation (PND 66–70 ± 3
for Experiments 1 and 2 and PND 90–120 for Experiment 3 at the start of testing). Animals
were maintained on a 12-hour reverse light/dark cycle with lights OFF at 0700 (Experiment
1), 0900 (Experiment 2), or 1300 (Experiment 3). Temperature and humidity were held
constant near 20° C and 50%, respectively. Food and water were available ad libitum.
Principles of laboratory animal care were followed and experiments were performed under a
protocol approved by the IUPUI School of Science Institutional Animal Care and Use
Committee.
Drinking Solutions
Ethanol (190 proof; Pharmco Inc., Brookfield, CT) was diluted to 20% (v/v) in tap water.
Caffeine (Sigma-Aldrich) was dissolved in tap water (0.03 % w/v or 0.05% w/v). The 0.03%
concentration is roughly equivalent to that of standard energy drinks (e.g. Red Bull©). The
higher 0.05% concentration of caffeine was included as the rapid metabolism of the mouse
may hinder the ability of caffeine to alter alcohol intoxication and/or intake. For the
combined ethanol and caffeine solution, 20% ethanol was mixed with caffeine at either a
0.03% (w/v) or 0.05% (w/v) concentration.
Drinking in the Dark
Beginning 3 hours into the dark cycle, singly housed male B6 mice had their water bottles
replaced by a 10 ml sipper tube containing tap water vehicle (W), ethanol (20% v/v; E),
caffeine (0.03 or 0.05% w/v; C3 or C5), or combined ethanol and caffeine (EC3 or EC5) for
2 hours. During this period, the only fluid available was the designated test fluid.
Home Cage Locomotor Activity Monitors
Details concerning the exact monitors (Columbus Instruments Inc., Columbus, OH) used in
the current study were previously published (Linsenbardt and Boehm, 2012). Each day,
animals’ cages were moved into the activity monitors immediately prior to lights out to
allow a full 3 hours for habituation prior to DID and mice were allowed to sit for at least 30
minutes following DID before being moved out of the monitors.
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Balance Beam
Our balance beam apparatus and procedure were recently described (Linsenbardt et al.,
2011). Ataxia was assessed by recording the number of times an animal’s hind feet slipped
off of the edges of the beam as it was traversed. All tests occurred in dim red light.
Elevated Plus Maze
Detailed methods for the elevated plus maze (EPM) are described elsewhere (Moore et al.,
2011). Mice were placed in the center of the EPM and behavior was recorded by a
camcorder mounted above the apparatus for 5 minutes. The luminance at the center of the
EPM was 90 lux (± 3). Videos were coded for time spent in the open and closed arms
separately with anxiety-like behavior being characterized by animals spending significantly
more time in the closed relative to the open arms.
Novel Object Recognition
Our procedure was modeled after Ryabinin and colleagues (2002). All procedures occurred
under red light (~8 lux). Animals were habituated to the testing arena (L: 40cm × W: 40 cm
× H: 28cm) following lights out for 10 minutes on 3 successive days. The following day,
mice were placed in the arena for a training trial immediately following the 2-hr DID session
with two identical objects in opposite corners of the arena for 10 minutes. The following test
day, mice were placed in the arena with a single object they had explored the previous day
as well as a novel object. During all sessions, activity was recorded via video tracking using
ANY-Maze software (Stoelting). Total exploration time (time spent sniffing or contacting
both objects) was recorded by an experimenter blind to condition via direct video
observation during both the training and test sessions. A photo of the objects can be found in
the supplementary material.
Experiment 1: The effect of caffeine and ethanol co-consumption on home
cage locomotor activity—Mice (n = 12–13) were given daily limited access to W, E,
C3, C5, EC3, or EC5 for 14 days via DID, during which home cage locomotor activity was
recorded. Mice from the E, EC3, and EC5 groups had periorbital blood samples collected
following access on day 14 for BEC analysis by an Analox Alcohol Analyzer (Analox
Instruments, Lunenburg, MA).
Experiment 2: The effect of caffeine and ethanol co-consumption on ethanol-
induced ataxia—Mice (n = 12) were given access to W, E, C3, or EC3 15 days. Only the
0.03% concentration of caffeine was used from this point forward because the 0.05%
concentration may have interfered with alcohol intake/BEC (Figure 1) in Experiment 1.
Ataxia testing on the balance beam was conducted following DID on days 8 and 15. On day
16, mice were administered an acute challenge of ethanol (1.75 g/kg, i.p.; 20% v/v in saline)
in place of DID and were tested for ataxia 10 minutes later to allow for full ethanol
absorption. Blood samples were taken immediately following the test and again at 40 and 90
minutes following injection in order to evaluate the effect of consumption history on ethanol
metabolism.
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Experiment 3: The effect of caffeine and ethanol co-consumption on anxiety-
like behavior and novel object recognition—Mice (n = 6) were given access to W, E,
C3, or EC3 for 8 days via DID. Following DID on day 3, each mouse was transported into
the EPM testing room and placed in the center of the apparatus and video was recorded for
the 5 minute test. On days 5–7, mice were habituated to the NOR arena. Immediately after
DID on day 8, mice were placed in the arena for training. On day 9, no DID occurred and
the animals were tested for NOR at the same time they were previously trained on day 8.
Behavioral testing did not occur until day 3 to limit the influence of DID novelty on
behavior (Linsenbardt and Boehm, 2012). As our data from Experiment 1 also suggested
that ethanol-induced locomotor sedation could interfere with task performance after ~ 8–9
days of consecutive access, we compacted the timeline of this experiment.
Statistical Analysis
Data were analyzed by Analysis of Variance (ANOVA) or t-test. As we were interested in
addressing the potential interaction between caffeine and ethanol, ‘ethanol’ [yes (EC3/E) or
no (C3/W)] and ‘caffeine’ [yes (C3/EC3) or no (W/E)] were factors in the relevant ANOVA
analyses. This allowed us to evaluate whether or not there were main effects of caffeine/
ethanol, or an interaction. Repeated measures ANOVAs also included day or time as the
within-subjects factor. The descriptors ‘ethanol’ and ‘caffeine’ in the results section below
refer to these aforementioned designations. The significance level was set at p < 0.05 and
Newman-Keuls post-hoc statistics were run where applicable. All analyses were carried out
with Statistica 7 software (Statsoft).
RESULTS
Experiment 1: The effect of caffeine and ethanol co-consumption on home cage locomotor
activity
Fluid Consumption and BEC—The 0.03% analysis (W, E, C3, EC3) of total fluid
intake found that ethanol-consuming groups (E/EC3) consumed significantly less fluid than
the non-ethanol consuming groups (C3/W); F1,48 = 7.944; p < 0.01, Figures 1A/B. This
pattern is consistent with what we typically observe in DID (Linsenbardt and Boehm, 2012,
Linsenbardt and Boehm, 2013). For the 0.05% analysis (W, E, C5, EC5), no factors or
interactions reached statistical significance (all p’s > 0.083; Figures 1A/C).
Ethanol intake (E, EC3, EC5) did not differ between groups across DID (Figure 1A; p > .
05), although the EC5 group trended towards a lower mean BEC following DID on day 14
(E = 164.0 mg/dL ± 13.9; EC3 = 174.5 mg/dL ± 16.07; EC5 = 130.3 mg/dL ± 9.51; F2,38 =
2.96, p = 0.06). A main effect of caffeine concentration was found for caffeine intake (F1,47
= 31.08, p < 0.001) with the C5 and EC5 groups consuming significantly more caffeine
overall than both the C3 and EC3 groups (Figures 1B/C). A caffeine concentration × ethanol
interaction trended toward significance (F1,47 = 3.26, p = 0.07) suggesting slightly greater
caffeine intake in C3 versus EC3 mice and this was confirmed by a follow up test (F1,24 =
5.649, p < 0.05).
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Locomotion—Analyses were split by caffeine concentration. For the 0.03% concentration
analysis (W, E, C3, EC3), a main effect of caffeine was found (F1,48 = 40.968, p < 0.001)
with the C3/EC3 groups being more active (p < 0.05) (Figure 2A). Ethanol was not a
significant factor for activity due to the extreme difference between E and EC3. The overall
activity of the E and W groups did not significantly differ (p > 0.05), however a planned
comparison of the activity data slopes over days between these groups revealed a significant
difference (F1,360 = 7.877, p < 0.01) with the E group demonstrating a negative trend,
indicating locomotor sedation (Figure 2A). Both caffeine (F13,624 = 2.901, p < 0.001) and
ethanol (F13,624 = 2.286, p < 0.01) significantly interacted with day. Follow-up analyses
determined that the EC3 group exhibited particularly high activity on day 1 (p < .05) and
W/C3 groups progressively decreased their activity over the course of the experiment
(Figure 2A; p < .05). For the 0.05% caffeine analysis, again a main effect of caffeine was
found (F1,47 = 26.173, p < 0.001) with the C5/EC5 groups being more active (Figure 2B). A
significant caffeine × day interaction was also detected (F13,611 = 2.28, p < 0.01), with non-
consuming groups (E/W) exhibiting steady decline in activity across days, although this was
largely driven by the E group. A significant ethanol × caffeine × day interaction was
detected (F13,611 = 3.08, p < 0.001) with the degree of difference between the C5 and W
group being smaller and fluctuating to a greater extent than the difference between EC5 and
W.
As ambulatory activity during DID sessions was also of interest, we analyzed the pattern of
home cage activity early on (day 3; Figure 3, panels A&B) and late (day 14; Figure 3, panels
C&D) in the 14-day DID procedure. Day 3 was chosen rather than days 1 or 2 due to
previous findings in our lab that the novelty of the DID procedure can influence the
locomotor effects of ethanol (Linsenbardt and Boehm, 2012). On day 3, a main effect of
caffeine was found with C3/EC3 groups exhibiting greater activity (F1,48 = 13.676, p <
0.001). A significant caffeine × time interaction (F11,528 = 4.516, p < 0.001) also indicated
that this difference was apparent from the 50 minute time point onward (p < .05). The
analysis of the 0.05% caffeine concentration also indicated that caffeine groups (C5/EC5)
exhibited greater activity (F1,47 = 13.102, p < 0.001). Caffeine also interacted with time
(F11,517 = 3.348, p < 0.001) with this difference also occurring at the 50 minute time point
and beyond (p < .05) with the exception of the 110 minute bin. A significant caffeine ×
ethanol × time interaction (F11,517 = 2.386, p < 0.01) was also found with caffeine
promoting significant differences in locomotor activity between the EC5 and E groups
within the 60–90 minute bins (p < .05).
The analysis of day 14 home cage data for the 0.03% concentration found a main effect of
caffeine (F1,48 = 32.591, p < 0.001) with the C3/EC3 groups being significantly more active.
An ethanol × caffeine interaction was also significant (F1,48 = 5.594, p < 0.05), indicating
that caffeine produced a substantial difference between the E and EC3 groups. In addition,
caffeine significantly interacted with time (F11,528 = 3.743, p < 0.001), indicating that the
EC3/C3 groups were significantly more active at the 30 minute time point and beyond (p < .
05). For the 0.05% analysis, a main effect of caffeine (F1,47 = 45.9, p < 0.001), as well as an
interaction with ethanol (F1,47 = 9.67, p < 0.01) were found. Post-hoc testing revealed that
the EC5 group was significantly more active than all other groups, overall (p < .05). In
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addition, caffeine significantly interacted with time (F11,517 = 6.97, p < 0.001), indicating
that the C5/EC5 groups were significantly more active at the 30 minute time point and
beyond (p < .05).
Experiment 2: The effect of caffeine and ethanol co-consumption on ethanol-induced
ataxia
Fluid Consumption—Ethanol-consuming groups consumed more fluid, overall (F1,44 =
4.169, p < .05; Figure 4). Significant caffeine × day (F14,294 = 3.061, p < 0.001) and ethanol
× day interactions were also found (F14,616 = 3.023, p < 0.001), with the C3/W groups
drinking particularly low volumes of fluid on days 12–14 (p < 0.05); an effect likely
representative of reactivity to the first ataxia test. Overall ethanol or caffeine intake did not
differ between the EC3 and E/C3 groups, respectively, across the experiment (p > 0.05).
Ataxia—Following fluid access on day 8, a main effect of ethanol was found with the
E/EC3 groups being significantly ataxic on the balance beam (Figure 5A; F1,44 = 18.77, p <
0.001). An ethanol × caffeine interaction approached significance (F1,44 = 3.3, p = 0.076)
with ethanol trending towards producing a greater difference between E/W than EC3/C3.
Ethanol-consuming groups (E/EC3) were also found to be significantly more ataxic
following access on day 15 (Figure 5B; F1,44 = 6.56, p < 0.05), however, a significant
caffeine × ethanol interaction (F1,44 = 5.254, p < 0.05) revealed that E group drove this main
effect as the EC3 group was significantly less ataxic than the E group (p < .05) and not
different from the C3 or W groups (p > .05).
Ethanol-consuming (E/EC3) mice were found to be significantly less ataxic following the
1.75 g/kg ethanol challenge on day 16 (F1,44 = 62.035, p < 0.001), illustrating significant
behavioral tolerance (Figure 5C). Finally, metabolic tolerance was observed in ethanol-
consuming (E/EC3) mice as they cleared ethanol more rapidly than those that did not (F1,44
= 16.77, p < 0.001) (Figure 5D). Caffeine exposure had no effect on ethanol metabolism (p
> 0.05).
Experiment 3: The effect of caffeine and ethanol co-consumption on anxiety-like behavior
and novel object recognition
Fluid Intake—No differences between groups were detected for overall fluid, ethanol, or
caffeine intake over days (p > 0.05; Figure 6). Intake was also not different between groups
on day 3 prior to EPM testing or day 8 prior to NOR training (p > .05)
Elevated Plus Maze—Following DID on day 3, a main effect of ethanol was found with
E/EC3 groups spending significantly more time in the open arms of the maze (F1,19 = 6.84,
p < 0.05). Follow up t-tests confirmed that both the W (t10 = 3.248, p < .01) and C3 (t8 =
3.615, p < .01) groups exhibited significant anxiety-like behavior as indicated by a strong
preference for the closed, relative to the open arms of the EPM whereas the E and EC3
groups showed no such preference (p’s > 0.05; Figure 7A). No differences were found
between groups in total or open arm entries (p’s > 0.05) (Figure 7B).
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Novel Object Recognition—Across the 3 habituation days (days 5–7), the activity of all
animals in the NOR arena significantly decreased as indicated by a main effect of day (F2,38
= 95.22, p < 0.001; Figure 8A), suggesting habituation occurred. Following DID on day 8,
no group differences were detected for total exploration time or activity during training
(Figure 8B and C; p’s > 0.05). The activity of E/EC3 mice was slightly lower during the test
on day 9 (F1,19 = 5.926, p < 0.05; Figure 8D); importantly, however, exploration time did
not differ between groups (Figure 8E; p’s > 0.05). To quantify NOR, a discrimination index
was computed ((time with novel object - time with familiar object)/total exploration time).
As expected, the W (t5 = 3.501, p < 0.05) and C3 (t4 = 5.765, p < 0.01) groups exhibited
NOR as evidenced by indices significantly greater than ‘0’ (Figure 8F). However, neither
the E nor EC3 group exhibited significant NOR (p’s > 0.05).
Discussion
The present study demonstrated that caffeine altered some neurobehavioral consequences of
binge alcohol consumption typically seen in B6 mice using the DID paradigm. Although
ethanol consumption or resultant BEC was not altered, co-consumption produced no
evidence of alcohol-induced sedation at equivalent alcohol dosage and even produced a
highly stimulated state. Furthermore, caffeine was found to antagonize alcohol-induced
ataxia. However, co-consumption had no effect on alcohol-induced anxiolysis or cognitive
interference assessed by the EPM and NOR, respectively. Therefore, the capacity of caffeine
to alter ethanol intake may not be the primary consequence of co-consumption, but rather
how caffeine may alter the nature of intoxication.
To our knowledge, this study is the first to evaluate voluntary binge-like caffeine or
caffeinated ethanol consumption in mice. Previous studies have either systemically injected
caffeine (Kunin et al., 2000, Rezvani et al., 2013) or forced continuous access for long
durations (Hughes, 2011). In the present study, we demonstrated that male B6 mice will not
only voluntarily consume behaviorally relevant levels of caffeine, but will also consume
combined ethanol/caffeine solutions via DID, reaching BECs equivalent to animals that
consume ethanol alone. This is a key strength of this voluntary consumption model as the
EC and E groups match their ethanol dosing, allowing for more streamlined interpretation of
the capacity of caffeine to alter effects of alcohol. Although a different question, caffeine
may alter alcohol intake probed at later time points (beyond 2 hours). Male B6 mice will
drink alcohol to the point of sedation in the DID paradigm (Linsenbardt and Boehm, 2013;
current study), but this is not observed in combination with caffeine. Therefore, extending
the access period may allow more time for this activity difference to influence ethanol intake
differences between groups.
Findings from Experiment 1 highlighted that mice consuming EC solutions demonstrated no
evidence of sedation and were similarly stimulated to those that consumed caffeine alone.
We hypothesized that caffeine would antagonize the alcohol-induced sedation we typically
observe over repeated cycles of DID. Although caffeine appeared to reverse this aspect of
alcohol intoxication, we cannot directly conclude that this was not due to the robust
stimulant effect of caffeine. However, caffeine administration can reverse the sedative-
hypnotic effects of ethanol at a much higher dose of ethanol than mice self-administered in
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the present study (El Yacoubi et al., 2003). Furthermore, we observed that caffeine interferes
with alcohol-induced motor impairment on the balance beam (Figure 5A/B) and considering
these data, we speculate that reversal of sedation is likely. Additionally, considering the
equivalent degree of stimulation in the EC3 and C3 groups (Figure 2A), in light of
significantly lower caffeine intake by EC3 group (Figure 1B), as well as greater activity of
the EC5 group towards the end of the experiment (Figure 2B), there may be some evidence
of a mild additive effect as has been previously demonstrated with systemic administrations
(Hilbert et al., 2013). Finally, the observation that the EC3 group was significantly more
active than all other groups at equivalent ethanol intakes and lower caffeine intake on day 1
(Figure 2A) suggests a potential interaction of co-consumption with novelty.
It was also found that after 15 days, caffeine antagonized ethanol-induced ataxia in
Experiment 2 (Figure 5B). Previous studies suggest that the dose-response curve for caffeine
on ethanol-induced motor impairment is U-shaped, with mid-range doses appearing to
antagonize ataxia and low/high doses having no effect or even increasing impairment (Dar,
1988, Dar et al., 1987). Our data may suggest that mice consumed a mid-range dose,
effectively reducing motor impairment. As the reduction in ataxia was only a trend
following access on day 8 in the EC3 group, the duration of co-consumption may be
important for the observed effect of caffeine on ethanol-induced ataxia. It may therefore be
that caffeine facilitated the development of functional tolerance. The 1.75 g/kg ethanol
challenge on day 16 detected functional tolerance development in all mice that consumed
alcohol (E/EC3), consistent with previous observations of our lab (Linsenbardt et al., 2011).
While this finding may appear to conflict with the observations of ataxia test 2, EC3 mice
had only experienced ethanol intoxication in combination with caffeine, also likely at lower
peak ethanol concentrations than was produced by the injection. Finally, it is important to
note that differences between the E and EC groups outlined above cannot be due to
differential ethanol pharmacokinetics (Figure 5D). Previous studies have also shown that
caffeine (Kunin et al., 2000) or energy drink administration (Ferreira et al., 2004) does not
alter ethanol metabolism in rodents when simultaneously administered.
Caffeine did not alter all measures alcohol intoxication, however, with mice exhibiting
significant anxiolysis and affected NOR as a consequence of both E and EC consumption.
An acute injection of ethanol has been previously demonstrated to produce anxiolysis on the
EPM (Homanics et al., 1999) as well as impaired NOR performance in B6 mice (Ryabinin et
al., 2002), however this study is the first, to our knowledge, to demonstrate such effects as a
consequence of voluntary binge consumption. On their own, these new findings are
important for the field as validations of binge alcohol intoxication produced by the DID
model. However, they also highlight that co-consumption of caffeine selectively alters
certain aspects of voluntary binge alcohol intoxication, but not others.
Considering the locomotor effects of co-consumption demonstrated in Experiment 1, there
may be concern that these effects influenced behavior on the other tasks. However, our
activity measures in the other tasks (EPM and NOR) indicate no activity differences
produced by consumption of the various fluids (Figures 6B and 8B). Therefore, this
locomotor effect does not seem apparent outside of the home cage and likely does not
interfere with our other behavioral assessments. Furthermore, the NOR results may be
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reflective of state-dependent learning rather than actual ethanol impairment of NOR.
Although state-dependent learning is a possibility, these data nevertheless suggest that
ethanol-consumption (regardless of caffeine presence) influenced the exhibition of NOR in
some capacity, implying that this effect of ethanol intoxication persisted.
The mechanisms by which caffeine alters ethanol intoxication may be related to actions at
common effector systems. The adenosine system has been implicated in alertness and
wakefulness; effects produced by caffeine via the antagonism of adenosine receptors
(Fredholm et al., 1999). Ethanol also acts upon the adenosine system, preventing reuptake
via the inhibition of equilibrative nucleoside transporter 1 (ENT1) (Nagy et al., 1990). In the
current study, ethanol consumption produced significant markers of intoxication across all
tasks, however, caffeine was only found to alter aspects of alcohol-induced motor
impairment (sedation and ataxia). Therefore, caffeine may have more potently modulated
alcohol-affected neurotransmission in regions involved in ambulation and coordination (e.g.
motor cortex, striatum, cerebellum). The resultant increase in extracellular adenosine
induced by ethanol likely contributes to its sedative-hypnotic and motor-impairing effects
which are blunted in ENT1 knockout mice (Choi et al., 2004) and can be mitigated by an
injection of caffeine in wildtype mice (El Yacoubi et al., 2003). In general, the A1 subtype
of the adenosine receptor appears to be more important for caffeine’s ability to antagonize
ethanol-induced motor incoordination whereas the A2A receptor appears to be more
important in regulating the sedative-hypnotic effects of ethanol (see Lopez-Cruz et al., 2013
for review). It is not clear why caffeine modulated aspects of alcohol intoxication mediated
by both of these receptor subtypes, but did not affect recognition memory or anxiety-like
behavior, both of which have been demonstrated to be positively influenced by acute
caffeine administration in the absence of ethanol (Prediger et al., 2005, El Yacoubi et al.,
2000). One reason may be that the oral doses of caffeine consumed by mice in the current
study (~10–15 mg/kg) do not reach the same peak concentrations in brain resulting from the
injected doses (10–100 mg/kg; i.p.) that produced these effects. Another potential issue is
that ethanol influences a host of other neurotransmitter systems (e.g. GABA, DA, GLU)
which may convolute caffeine’s ability to modify ethanol’s effect on such complex
cognitive-behavioral modalities as recognition memory and anxiety. Future work addressing
the role of adenosine receptor subtypes in specific brain regions involved in these various
behaviors will clarify the receptor/phenotype specificity of caffeine’s potential to alter
alcohol intoxication.
Our results echo a number of intriguing findings in the human literature. Heightened
subjective stimulation has been observed following energy drink co-consumption relative to
alcohol alone (Attwood et al., 2012, Peacock et al., 2013a). Caffeine and energy drinks have
been shown to antagonize fatigue (Drake et al., 2003, Marczinski et al., 2012) as well as
improve decrements in reaction time (Drake et al., 2003, Azcona et al., 1995) associated
with alcohol use; observations potentially associated with a stimulated state. In addition,
caffeine has been found to attenuate some aspects of psychomotor impairment produced by
ethanol consumption (Drake et al., 2003, Howland et al., 2011). However, ethanol-
associated lightheadedness and cognitive deficits were still found to persist in individuals
that consumed a combined solution (Drake et al., 2003, Heinz et al., 2013), suggesting that
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some aspects of intoxication remain when individuals are under the influence of both
compounds.
In conclusion, the present study characterized an animal model of binge ethanol and caffeine
co-consumption that has the capacity to significantly improve the translational validity of
preclinical research on this topic. These findings align with human self-report data on the
motivation to consume caffeinated alcoholic beverages as well as empirical data. The altered
neurobehavioral state of co-consumption relative to ethanol intoxication alone is of concern
as intoxicated individuals may not only be less sedated, but stimulated, less ataxic, and less
anxious; a state which may influence decisions to engage in impulsive/risky behaviors
(O’Brien et al., 2008, Amlung et al., 2013, O’Brien et al., 2013). This new approach can be
valuable in advancing our understanding of the motivation for and consequences of binge
ethanol and caffeine co-consumption as well as elucidating their neurobiological
mechanisms. As this type of drinking behavior is rather new, its public health consequences
are likely not yet fully realized and enhancing our understanding of its acute and protracted
neurobiological effects should be paramount.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Daily fluid intakes over the course of the 14 day DID procedure in Experiment 1 (n = 12–
13). Where represented, the water (W) group is the same 12 animals and these animals only
had access to water in DID. The symbols for W groups only indicate fluid volume
consumed, not ethanol or caffeine intake. A) Average ethanol intake in animals that had
access to some form of ethanol. B) Average caffeine intake for animals that had access to
0.03% caffeine. C) Average caffeine intake for animals that had access to 0.05% caffeine.
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Figure 2.
Home cage locomotor activity during DID access periods over the course of the 14 day DID
procedure in Experiment 1 (n = 12–13). The E and W groups in both panels represent the
same groups of animals. A) Average locomotor activity for animals that had access to 0.03%
caffeine relative to W and E animals. Gray regression line demonstrates statistically
significant negative slope of the measurements for the E group over days (R2 = 0.154, p <
0.001). B) Average locomotor activity for animals that had access to 0.05% caffeine relative
to the same W and E animals.
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Figure 3.
Home cage locomotor activity during DID access periods on days 3 and 14 of Experiment 1
(n = 12–13). The E and W groups in the 0.03% and 0.05% panels are identical. A,B)
Average locomotor activity in 10 minute bins for animals that had access to 0.03% or 0.05%
caffeine relative to W and E animals during DID on day 3. C,D) Average locomotor activity
in 10 minute bins for animals that had access to 0.03% or 0.05% caffeine relative to W and
E animals during DID on day 14.
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Figure 4.
Daily fluid intake over the course of the 15 day DID procedure in Experiment 2 (n = 12). A)
Average ethanol intake in animals that had access to some form of ethanol. Ethanol intake
was not different between groups prior to ataxia test 1 on day 8 (E = 3.914 g/kg ± 0.246,
EC3 = 4.284 g/kg ± 0.24; p > 0.05) or ataxia test 2 on day 15 (E = 4.248 g/kg ± 0.268, EC3
= 4.703 g/kg ± 0.324; p > 0.05). B) Average caffeine intake for animals that had access to
some form of caffeine. Arrows denote the ataxia tests conducted after DID access on days 8
and 15.
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Figure 5.
Balance beam assessment of ataxia immediately following DID access A) on day 8 and B)
day 15 of Experiment 2. C) Functional tolerance to ethanol alone was also assessed on day
16 with a 1.75 g/kg injection of ethanol (i.p.), where no DID access was given, 10 minutes
before animals were tested on the beam. D) BEC values from samples collected at 11, 40,
and 90 minutes after the 1.75 g/kg ethanol challenge on day 16. *p < 0.05, **p < 0.01, ***p <
0.001 versus the W group. #p < 0.05, ###p < 0.001 versus the C3 group. $p < 0.05 versus the
EC3 group; n = 12.
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Figure 6.
Daily fluid intake over the course of the 8 day DID procedure in Experiment 3 (n = 6). A)
Average ethanol intake in animals that had access to some form of ethanol. B) Average
caffeine/fluid intake for animals that had access to some form of caffeine or water.
Fritz et al. Page 19
Alcohol Clin Exp Res. Author manuscript; available in PMC 2015 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7.
Elevated plus maze assessment of anxiety-like behavior following DID access on day 3 in
Experiment 3. A) Time spent in the open and closed arms in each group expressed as a
percentage of the total 5 minute test. B) Entries into the open arms or total arm entries as an
index of activity. **p < 0.01 for difference between open and closed arms within the
designated group; #p < 0.05 for main effect of ethanol on the open arms with the E/EC3
groups spending significantly more time in the open arms than the W/C3 groups; n = 6 (5 for
C3).
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Figure 8.
Behavioral measures over the course of the NOR procedure in Experiment 3. A) Activity
during the 3 habituation periods on days 5–7. B,D) Total distance traveled in meters during
training on day 8 and the NOR test on day 9. C,E) Total time spent exploring both objects
during training on day 8 or the NOR test on day 9. F) Discrimination index on day 9
indicating the degree of novel object preference with a ‘0’ value indicating indifference. p*
< 0.05, **p < 0.01 versus ‘0’; #p < 0.05 for main effect of ethanol consumption history; n = 6
(5 for C3).
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